2026-525271-57-00RecruitingPhase 1
A research study looking into how a single dose of the medicine NNC0537-1482 moves through the body of participants with normal or reduced kidney function
Source: EU CTIS (euclinicaltrials.eu) · Last updated 19 Oct 2026
- Status (registry)
- Recruiting
- Phase (registry)
- Phase 1
- Study type
- Interventional
- Enrollment
- 54 (estimated)
- First submitted
- 17 Jun 2026
- Start date
- 31 Aug 2026
- Lead sponsor
- Novo Nordisk A/S
- Diseases
- Heart failure
- EU CT number
- 2026-525271-57-00
What you commit to
- Study type: Interventional · Phase 1
- Planned participants: 54
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Charite Research Organisation GmbH | Berlin | Germany | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.